EUVIMEDEUVIMED entdecken
Metaanalyse

Computed tomography‐derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta‐analysis of observational studies

Michel Pompeu Sá iD, Jef Van den Eynde, Xander Jacquemyn, Ozgun Erten, Roberto Rodriguez, Scott Goldman, Paul M Coady, Eric Gnall, William A Gray iD, Harish Jarrett, Sandra V Abramson, Marie-Annick Clavel und 2 weitere

Catheterization and Cardiovascular Interventions · 2023-06 · 101 (7) · 1203-1213

DOI: 10.1002/ccd.30666 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 18.04.2023. Verfasst von Michel Pompeu Sá und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Lankenau Medical Center, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania, USA. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Pacemaker, Artificial, Aortic Valve Stenosis, Heart Valve Prosthesis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is associated with higher risk of mortality and rehospitalization for heart failure. Efforts to prevent conduction abnormalities (CA) requiring PPI after TAVI should be made. The membranous septum (MS) length and its interaction with implantation depth (ID–ΔMSID) could provide useful information about the risk of CA/PPI following TAVI.

Objectives

To identify MS length and ΔMSID as predictors of CA/PPI following TAVI.

Methods

Study‐level meta‐analysis of studies published by September 30, 2022.

Results

Eighteen studies met our eligibility including 5740 patients. Shorter MS length was associated with a significantly higher risk of CA/PPI (per 1 mm decrease: odds ratio [OR] 1.60, 95% confidence interval [CI] 1.28–1.99, p < 0.001). Similarly, lower ΔMSID was associated with a significantly higher risk of CA/PPI (per 1 mm decrease: OR 1.75, 95% CI 1.32–2.31, p < 0.001). Meta‐regression analyses revealed a statistically significant modulation of the effect of shorter MS length and lower ΔMSID on the outcome (CA/PPI) by balloon postdilatation (positive regression coefficients with p < 0.001); with increasing use of balloon postdilatation, the effect of shorter MS length and lower ΔMSID on the outcome increased. MS length and ΔMSID demonstrated excellent discriminative abilities, with diagnostic ORs equaling 9.49 (95% CI 4.73–19.06), and 7.19 (95% CI 3.31–15.60), respectively.

Conclusion

Considering that short MS length and low ΔMSID are associated with higher risk of CA and PPI, we should include measurement of MS length in the pre‐TAVI planning with MDCT and try to establish optimal ID values before the procedure to avoid CA/PPI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementPacemaker, ArtificialAortic Valve StenosisHeart Valve ProsthesisHumansRisk FactorsTreatment OutcomeTomography, X-Ray ComputedAortic Valve

Stichwörter der Autor:innen

aortic valvecardiac surgical procedurescardiovascular surgical proceduresheart valve prosthesis implantationheart valvesmeta-analysistranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Lankenau Medical Center, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania, USA.
  • Department of Cardiothoracic Surgery Research, Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA.
  • Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
  • Department of Interventional Cardiology, Lankenau Medical Center, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania, USA.
  • Department of Cardiovascular Imaging, Lankenau Medical Center, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania, USA.
  • Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec City, Québec, Canada.

ORCID-Profile: Michel Pompeu Sá, William A Gray

Zitieren

APA

Sá, M. P., Van den Eynde, J., Jacquemyn, X., Erten, O., Rodriguez, R., Goldman, S., Coady, P. M., Gnall, E., Gray, W. A., Jarrett, H., Abramson, S. V., Clavel, M. A., Pibarot, P., & Ramlawi, B. (2023). Computed tomography‐derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta‐analysis of observational studies. Catheterization and Cardiovascular Interventions, 101(7), 1203-1213. https://doi.org/10.1002/ccd.30666

Vancouver

Sá MP, Van den Eynde J, Jacquemyn X, Erten O, Rodriguez R, Goldman S, et al. Computed tomography‐derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta‐analysis of observational studies. Catheterization and Cardiovascular Interventions. 2023;101(7):1203-1213. doi:10.1002/ccd.30666

BibTeX
@article{S2023,
  author = {Sá, Michel Pompeu and Van den Eynde, Jef and Jacquemyn, Xander and Erten, Ozgun and Rodriguez, Roberto and Goldman, Scott and Coady, Paul M and Gnall, Eric and Gray, William A and Jarrett, Harish and Abramson, Sandra V and Clavel, Marie-Annick and Pibarot, Philippe and Ramlawi, Basel},
  title = {Computed tomography‐derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta‐analysis of observational studies},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  volume = {101},
  number = {7},
  pages = {1203--1213},
  doi = {10.1002/ccd.30666}
}
Kostenlos starten →